![Jun Axup](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Ehemalige bekannte Positionen von Jun Axup
Unternehmen | Position | Ende |
---|---|---|
SOSV Ltd.
![]() SOSV Ltd. Investment ManagersFinance Sosv Ltd (Sosv) is a multi-stage venture capital and accelerator firm founded by Sean O’Sullivan in 1994. The firm is headquartered in Ireland with an additional offices in Luxembourg, USA, Hong Kong and China. | Private Equity Investor | 01.03.2022 |
Myi Diagnostics & Discovery, Inc.
![]() Myi Diagnostics & Discovery, Inc. BiotechnologyHealth Technology MYi Diagnostics & Discovery, Inc. provides diagnostic assays for longitudinal profiling of blood and other tissues applicable to the monitoring of healthy, disease-predisposed, and treated individuals. The firm also develops multiplexed immunocytochemical analytical platforms for assaying patient biopsies to identify the unique biomarkers that identify diseased cells. The company was founded by Nicholas J. Schork, Devon Cayer, and Kristopher L. Nazor on September 8, 2015 and is headquartered in San Diego, CA. | Gründer | 01.06.2016 |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 2 |
---|---|
SOSV Ltd.
![]() SOSV Ltd. Investment ManagersFinance Sosv Ltd (Sosv) is a multi-stage venture capital and accelerator firm founded by Sean O’Sullivan in 1994. The firm is headquartered in Ireland with an additional offices in Luxembourg, USA, Hong Kong and China. | Finance |
Myi Diagnostics & Discovery, Inc.
![]() Myi Diagnostics & Discovery, Inc. BiotechnologyHealth Technology MYi Diagnostics & Discovery, Inc. provides diagnostic assays for longitudinal profiling of blood and other tissues applicable to the monitoring of healthy, disease-predisposed, and treated individuals. The firm also develops multiplexed immunocytochemical analytical platforms for assaying patient biopsies to identify the unique biomarkers that identify diseased cells. The company was founded by Nicholas J. Schork, Devon Cayer, and Kristopher L. Nazor on September 8, 2015 and is headquartered in San Diego, CA. | Health Technology |